Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06747598 · ClinicalTrials.gov registry record
Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
A clinical trial of Pregnancy Testing, sponsored by University of Nebraska.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT06747598: Completed study of Pregnancy Testing, sponsored by University of Nebraska.
NCT06747598 is a study of Pregnancy Testing that has completed, run by University of Nebraska. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06747598, a study of Pregnancy Testing, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the efficacy of using peripheral blood for POC pregnancy testing in known pregnant participants.
Primary Outcome
A peripheral serum sample was collected through a finger stick point-of-care (POC) test to assess pregnancy in 30 women with previously confirmed pregnancies. The results were reported as either positive or negative.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST pregnancy test
Study Locations (1)
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-26 |
| Est. Completion | 2025-08-01 |
What the finished NCT06747598 record still lists
NCT06747598 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Pregnancy Testing appearing as the primary indexed condition, and to 1 intervention - of which pregnancy test is the first listed.
NCT06747598 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT06747598 about?
NCT06747598 is a clinical study titled "Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing". To evaluate the efficacy of using peripheral blood for POC pregnancy testing in known pregnant participants.
What is the current status of trial NCT06747598?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2025-02-26. Estimated completion is 2025-08-01.
What conditions does trial NCT06747598 study?
This clinical trial studies the following conditions: Pregnancy Testing.
What interventions are being tested in trial NCT06747598?
The interventions under investigation include: pregnancy test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06747598?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06747598 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI